Cincinnati.com: UC joins national COVID impact study; you could be recruited for it

UC expert provides details on COMPASS study

Maggie Powers-Fletcher, PhD, of the Division of Infectious Diseases at the UC College of Medicine, was interviewed by Cincinnati.com about the COMPASS study she is leading. The study is part of the efforts by the COVID-19 Prevention Network launched by the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health. It will examine the impact of COVID-19 on communities across the United States.

Dr. Margaret Powers-Fletcher is leading the COMPASS trial on community impact of COVID-19.

Maggie Powers-Fletcher, PhD, of the Division of Infectious Diseases at the UC College of Medicine. Photo/Colleen Kelley/UC Creative + Brand

When the study is ready for enrollment, residents who happen to be in several pre-selected locations, or "pop-up sites" in public spaces around Cincinnati, will be recruited. The sites and recruitment efforts won't be announced in advance, so as not to taint the integrity of the study.

"I think it’s so cool that Cincinnati is involved and there’s no one else in our region that is doing this. This helps put Cincinnati on the map," Powers-Fletcher said. "This gives our community a voice in the larger federal government response of how we’re approaching solutions and approaching research related to this pandemic.” 

Read the entire story here. See more coverage of the story from WLWT, WVXU and the Cincinnati Business Courier. Read more about the COMPASS study here

Lead photo/Colleen Kelley/UC Creative + Brand

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories

1

Sugar overload killing hearts

November 10, 2025

Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.

2

Is going nuclear the solution to Ohio’s energy costs?

November 10, 2025

The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.

3

App turns smartwatch into detector of structural heart disease

November 10, 2025

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.